Delivery Order SPE2DB22D1002-SPE2DB25FLHD1
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,132.00 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order valued at $19,528.99 to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on August 8, 2025, with completion expected by August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xeljanz is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a $28.8K delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on September 15, 2025, with completion scheduled for September 16, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg, a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions. Valued at $6,829.57 with a firm fixed price and no set-aside designation, this competitively awarded contract was executed on August 26, 2025, with an ultimate completion date of August 27, 2025. The order is being fulfilled at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $24,078.22 to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,313.78 to supply Xeljanz XR 11 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xeljanz XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order valued at $25,569.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets in quantities of 60 units. This firm fixed price delivery order, issued on July 30, 2025, is set to be completed by July 31, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $25.5K to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Xeljanz XR is a branded immunosuppressant medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg, a pharmaceutical product used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitive, non-set-aside contract, valued at $2,801.15, was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $22,621.69 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...